143 related articles for article (PubMed ID: 36464772)
1. Co-inhibition of immunoproteasome subunits LMP2 and LMP7 enables prevention of transplant arteriosclerosis.
Li J; Hu S; Johnson HWB; Kirk CJ; Xian P; Song Y; Li Y; Liu N; Groettrup M; Basler M
Cardiovasc Res; 2023 May; 119(4):1030-1045. PubMed ID: 36464772
[TBL] [Abstract][Full Text] [Related]
2. Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
Li J; Basler M; Alvarez G; Brunner T; Kirk CJ; Groettrup M
Kidney Int; 2018 Mar; 93(3):670-680. PubMed ID: 29229189
[TBL] [Abstract][Full Text] [Related]
3. Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity.
Basler M; Lindstrom MM; LaStant JJ; Bradshaw JM; Owens TD; Schmidt C; Maurits E; Tsu C; Overkleeft HS; Kirk CJ; Langrish CL; Groettrup M
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30279279
[TBL] [Abstract][Full Text] [Related]
4. Optimization of α-amido boronic acids via cryo-electron microscopy analysis: Discovery of a novel highly selective immunoproteasome subunit LMP7 (β5i)/LMP2 (β1i) dual inhibitor.
Arai Y; Shitama H; Yamagishi M; Ono S; Kashima A; Hiraizumi M; Tsuda N; Katayama K; Tanaka K; Koda Y; Kato S; Sakata K; Nureki O; Miyazaki H
Bioorg Med Chem; 2024 Jun; 109():117790. PubMed ID: 38906067
[TBL] [Abstract][Full Text] [Related]
5. Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factors.
Li J; Koerner J; Basler M; Brunner T; Kirk CJ; Groettrup M
Kidney Int; 2019 Mar; 95(3):611-623. PubMed ID: 30685098
[TBL] [Abstract][Full Text] [Related]
6. Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia.
Du SH; Xiang YJ; Liu L; Nie M; Hou Y; Wang L; Li BB; Xu M; Teng QL; Peng J; Hou M; Shi Y
Front Immunol; 2020; 11():603278. PubMed ID: 33552061
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Highly Selective Inhibitors of the Immunoproteasome Low Molecular Mass Polypeptide 2 (LMP2) Subunit.
Johnson HWB; Anderl JL; Bradley EK; Bui J; Jones J; Arastu-Kapur S; Kelly LM; Lowe E; Moebius DC; Muchamuel T; Kirk C; Wang Z; McMinn D
ACS Med Chem Lett; 2017 Apr; 8(4):413-417. PubMed ID: 28435528
[TBL] [Abstract][Full Text] [Related]
8. Immunoproteasome inhibition prevents progression of castration-resistant prostate cancer.
Li J; Liu N; Zhou H; Xian P; Song Y; Tang X; Li Y; Basler M
Br J Cancer; 2023 Mar; 128(7):1377-1390. PubMed ID: 36681728
[TBL] [Abstract][Full Text] [Related]
9. The antiviral immune response in mice devoid of immunoproteasome activity.
Basler M; Beck U; Kirk CJ; Groettrup M
J Immunol; 2011 Dec; 187(11):5548-57. PubMed ID: 22013127
[TBL] [Abstract][Full Text] [Related]
10. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A
Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764
[TBL] [Abstract][Full Text] [Related]
11. No prolongation of skin allograft survival by immunoproteasome inhibition in mice.
Mundt S; Basler M; Sawitzki B; Groettrup M
Mol Immunol; 2017 Aug; 88():32-37. PubMed ID: 28582644
[TBL] [Abstract][Full Text] [Related]
12. The Immunoproteasome Subunits LMP2, LMP7 and MECL-1 Are Crucial Along the Induction of Cerebral Toxoplasmosis.
French T; Israel N; Düsedau HP; Tersteegen A; Steffen J; Cammann C; Topfstedt E; Dieterich D; Schüler T; Seifert U; Dunay IR
Front Immunol; 2021; 12():619465. PubMed ID: 33968021
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the Immunoproteasome Subunit LMP7 with ONX 0914 Ameliorates Graft-versus-Host Disease in an MHC-Matched Minor Histocompatibility Antigen-Disparate Murine Model.
Zilberberg J; Matos J; Dziopa E; Dziopa L; Yang Z; Kirk CJ; Assefnia S; Korngold R
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1555-64. PubMed ID: 26093043
[TBL] [Abstract][Full Text] [Related]
14. Required Immunoproteasome Subunit Inhibition Profile for Anti-Inflammatory Efficacy and Clinical Candidate KZR-616 ((2 S,3 R)- N-(( S)-3-(Cyclopent-1-en-1-yl)-1-(( R)-2-methyloxiran-2-yl)-1-oxopropan-2-yl)-3-hydroxy-3-(4-methoxyphenyl)-2-(( S)-2-(2-morpholinoacetamido)propanamido)propenamide).
Johnson HWB; Lowe E; Anderl JL; Fan A; Muchamuel T; Bowers S; Moebius DC; Kirk C; McMinn DL
J Med Chem; 2018 Dec; 61(24):11127-11143. PubMed ID: 30380863
[TBL] [Abstract][Full Text] [Related]
15. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation.
Kalim KW; Basler M; Kirk CJ; Groettrup M
J Immunol; 2012 Oct; 189(8):4182-93. PubMed ID: 22984077
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Identification and Assessment of the Location of Immunoproteasome Subunits LMP2 and LMP7 in Acquired Cholesteatoma.
Rutkowska J; Kasacka I; Rogowski M; Olszewska E
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762439
[TBL] [Abstract][Full Text] [Related]
17. Anti-viral immune response in the lung and thymus: Molecular characterization and expression analysis of immunoproteasome subunits LMP2, LMP7 and MECL-1 in pigs.
Liu Q; Hu W; Zhang YL; Hu SP; Zhang Z; He XJ; Cai XH
Biochem Biophys Res Commun; 2018 Aug; 502(4):472-478. PubMed ID: 29856997
[TBL] [Abstract][Full Text] [Related]
18. Effective therapy of polymyositis in mice via selective inhibition of the immunoproteasome.
Del Rio Oliva M; Kirk CJ; Groettrup M; Basler M
Eur J Immunol; 2022 Sep; 52(9):1510-1522. PubMed ID: 35733374
[TBL] [Abstract][Full Text] [Related]
19. Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice.
Koerner J; Brunner T; Groettrup M
Oncotarget; 2017 Aug; 8(31):50873-50888. PubMed ID: 28881611
[TBL] [Abstract][Full Text] [Related]
20. A20-mediated modulation of inflammatory and immune responses in aortic allografts and development of transplant arteriosclerosis.
Siracuse JJ; Fisher MD; da Silva CG; Peterson CR; Csizmadia E; Moll HP; Damrauer SM; Studer P; Choi LY; Essayagh S; Kaczmarek E; Maccariello ER; Lee A; Daniel S; Ferran C
Transplantation; 2012 Feb; 93(4):373-82. PubMed ID: 22245872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
